Other analysts have also recently issued reports about the company. Numis Securities restated a hold rating and set a GBX 180 ($2.49) price target on shares of ConvaTec Group in a report on Thursday. Deutsche Bank restated a sell rating and set a GBX 180 ($2.49) price target on shares of ConvaTec Group in a report on Friday, December 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of Hold and an average price target of GBX 244.67 ($3.38).
Shares of ConvaTec Group (LON:CTEC) opened at GBX 215.30 ($2.97) on Thursday. The firm has a market capitalization of $4,200.00 and a PE ratio of 3,588.33. ConvaTec Group has a twelve month low of GBX 181.40 ($2.51) and a twelve month high of GBX 349.10 ($4.82).
ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.com-unik.info/2018/02/18/peel-hunt-reaffirms-hold-rating-for-convatec-group-ctec.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.